Pretreatment of mice with heat-killed Gram-positive bacteria, Propionibacterium acnes (P. acnes) markedly increases sensitivity to LPS. A small amount of LPS challenge into P. acnes-primed mice causes severe liver damage and death. 1 2,3 However, the triggering mechanism of the P. acnes-LPS system remains obscure.
INTRODUCTION
Pretreatment of mice with heat-killed Gram-positive bacteria, Propionibacterium acnes (P. acnes) markedly increases sensitivity to LPS. A small amount of LPS challenge into P. acnes-primed mice causes severe liver damage and death. 1 Recent work indicates that liver damage is induced by apoptotic mechanisms, in which Fas-ligandpositive CD4 + NK1.1 cells target Fas-positive hepatic cells. The Fas-ligand of CD4 + NK1.1 cells is upregulated by interleukins IL-18 and IL-12, which are produced by Kupffer cells (KC) and macrophages. 2, 3 However, the triggering mechanism of the P. acnes-LPS system remains obscure.
The roles of CD14 as the major receptor for LPS in vivo have been explored using CD14 transgenic and knockout mice. [4] [5] [6] The results of these studies suggest the involvement of CD14 in the liver damage as well as lethality in the P. acnes-LPS model. P. acnes treatment may provide a special environmental condition surrounding the liver and plasma with respect to CD14, leading to high sensitivity to LPS. The present experiments were undertaken to explore these issues.
RESULTS

Histological changes and CD14 expression in the liver in non-transgenic and CD14-transgenic mice after P. acnes-priming
The intraperitoneal injection of P. acnes (10 µg) in nontransgenic C57BL/6N mice induces polymorphs and monocytic cell infiltration in the sinusoid, and the subsequent granuloma formation consisted mainly of monocytic cells, peaking 7 days after the priming injection. To examine the involvement of CD14 in the LPS-induced liver injury in P. acnes-primed mice, we compared the reaction between non-transgenic (C57BL/6, B6) and transgenic (M14M) mice, which expressed CD14 in the liver and small intestine after zinc administration under the control of the metallothionein promoter. 5 The features of leukocyte infiltration and granuloma formation were almost identical to those in the B6 mice, but the size of the granulomas was smaller than that in the B6 mice. P. acnes was suggested to induce CD14 in KC because the expression of CD14 is strongly upregulated in KC after LPS stimulation 7, 8 and CD14 plays a role in the binding of a wide variety of microbial cell wall components including Gram-positive bacteria. 9 We, therefore, examined the expression of CD14 mRNA in the liver, and found that P. acnes induced a biphasic expression of CD14 in the liver in B6 mice. The first phase was observed 3-6 h after the injection and the second phase appeared around 5-7 days after P. acnes stimulation.
CD14 mRNA expression in the M14M mice was basically high and also biphasic, peaking 12 h and 6 days after the P. acnes injection. The immunostaining of CD14 revealed positive staining in KC in B6 mice, peaking 12 h after priming and declining thereafter. Subsequently, positive staining was found in infiltrating myeloid cells, especially monocytic cells. The expression of CD14 in KC in the M14M mice was comparable to that in the B6 mice. In addition, hepatocytes showed positive staining, which was found mainly in the cytoplasm in the early period up to 12 h and then at the cell surface. The second rise in CD14 mRNA expression in the B6 mice appeared to correspond to the accumulation of these cells. Staining was found in infiltrating cells in the M14M mice, although the number of positive cells was fewer than that in the B6 mice.
Histological changes and CD14 expression in the liver in P. acnes-primed B6 and M14M mice after LPS challenge
The P. acnes-primed B6 and M14M mice were challenged with an intraperitoneal injection of LPS (1 µg) 7 days after the priming. No hepatocyte damage was found by 6 h after the challenge. However, hepatocytes with necrotic and apoptotic changes appeared thereafter in the B6 mice. Such hepatic changes were found in regions associated with granulomas. These types of hepatocyte damage were seldom seen in the M14M mice.
The LPS challenge upregulated the CD14 mRNA expression in the B6 and M14M mice 1-12 h after stimulation. The levels in the M14M mice were higher than those in the B6 mice. The immunostaining of CD14 demonstrated staining in monocytic cells and KC in the B6 mice as a consequence of the expression of CD14 7 days after the priming, although the staining intensities were slightly upregulated. The CD14 expression in KC was prolonged compared with that in the mice without P. acnes-priming and in the first phase of upregulation in the liver in P. acnes-primed B6 mice. The LPS challenge of P. acnes-primed M14M mice markedly upregulated the membrane CD14 expression in hepatocytes in addition to the CD14 expression in monocytic cells and KC, which showed less marked expressions than that in B6 mice.
Cytokine and iNOS expression in the liver in P. acnesprimed B6 and M14M mice after LPS challenge
We next examined the expression of cytokines and inducible nitric oxide synthase (iNOS) which were reportedly involved in hepatocyte damage in a P. acnes-LPS model. TNFα mRNA expression in P. acnes-primed B6 mice was found 7 days after priming and was upregulated 1 h after the LPS (1 µg) injection, whereas that in P. acnes-primed M14M mice was marginal 7 days after priming and only slightly upregulated 1 h after LPS challenge (Fig. 1) .
The immunostaining of TNFα revealed staining in monocytic cells in granulomas and KC in B6 mice 7 days after priming, which was significantly upregulated after LPS injection, whereas the staining was very low in these cells in the M14M mice.
IFN-γ mRNA expression in B6 mice 7 days after P. acnes-priming was high. Upon LPS challenge, IFN-γ mRNA was slightly upregulated, becoming maximal 2 h after the challenge. In contrast, the IFN-γ mRNA expression in the P. acnes-primed M14M mice 7 days after P. acnes-priming and after LPS challenge was very low compared with that in the P. acnes-primed B6 mice. IL-12 mRNA expression was not found in P. acnes-primed B6 or M14M mice 7 days after P. acnes-priming. However, IL-12 mRNA expression in the B6 mice was markedly upregulated 1 h after LPS stimulation, whereas that in the M14M mice was less marked. IL-18 mRNA expression was high in the B6 mice 7 days after P. acnespriming and gradually upregulated after the LPS injection, whereas that in the M14M mice was also high but not upregulated. No iNOS mRNA expression in the liver was found in P. acnes-primed B6 mice. After the LPS challenge, the expression was induced, peaking at 3 h after LPS challenge. In contrast, no iNOS mRNA expression was observed in the liver in P. acnes-primed M14M mice before or after LPS challenge.
Soluble CD14 in the sera after P. acnes-priming and LPS challenge
The kinetics of the membrane-associated CD14 suggest that soluble CD14 (sCD14) can be produced and plays a role in P. acnes/LPS system. We, therefore, measured the kinetics of sCD14 levels in the sera after P. acnes-prim- ing and LPS challenge using a Western blot analysis. The sCD14 in P. acnes-primed B6 mice showed a biphasic increase roughly co-ordinating with the features of CD14 expression in the liver; 1-12 h and 7 days after P. acnes-priming. After the injection of LPS (1 µg), the levels of sCD14 slightly increased 6 h after the challenge and remained high thereafter compared with those in P. acnes-non-primed mice after LPS stimulation. In contrast, the challenge injection in P. acnes-primed M14M mice produced biphasic responses but higher sCD14 levels compared to those of the P. acnes-primed B6 mice. After the challenge, the levels were upregulated, peaking 12 h after challenge, although the level was transiently downregulated 3 h after challenge.
The increase in the challenge injection of LPS (2 µg) caused 100% lethality in P. acnes-primed B6 mice within 48 h after the challenge. The dose also resulted in 100% lethality in P. acnes-primed M14M mice, whereas the M14M mice showed no liver damage. Changes in the levels of sCD14 in sera may lead to the functional disturbance of endothelial cells. To investigate these observations, we measured the levels of expression of endothelial cell leukocyte adhesion molecule (ELAM-1) mRNA in several organs from P. acnes-primed B6 and M14M mice at 1 h after LPS challenge. The levels of expression in the heart, kidney, lung and spleen in M14M mice were upregulated 1 h after the challenge but significantly lower than those in B6 mice.
DISCUSSION
The levels of expression of cytokines and iNOS in M14M mice were lower than those in B6 mice in a P. acnes/LPS system. Less marked hepatocyte damage was observed in M14M mice compared with B6 mice. The plasma AST and ALT values of the B6 and M14M mice reflected the differences in their hepatocyte damage. Thus, these results clearly indicate the involvement of CD14 in the production of bioactive substances and hepatocyte damage of a P. acnes/LPS system.
The time course of upregulation of CD14 mRNA by P. acnes was 3 h after stimulation as that by LPS. 7 The expression of CD14 terminated by 12 h after the priming and reappeared 5-7 days after the priming. Immunostaining of the P. acnes-primed liver demonstrated that CD14 mRNA upregulation was correlated with leukocyte accumulation. Correspondingly, the number of CD14-positive monocytic cells increased in the granuloma, peaking at day 7 after P. acnes administration. The CD14 expression in M14M mice, in contrast, was characterized by high basal levels and prolonged expression, which were due to the expression in hepatocytes, especially in the cell membrane. P. acnes also induced biphasic sCD14 upregulation. Similar, but more marked, effects were observed in M14M mice, suggesting that sCD14 in addition to membrane CD14 was also produced, although the transgene was constructed to produce fulllength CD14.
The initial triggering of the infiltration of monocytic cells in the liver may be ascribable to the activation of KC by P. acnes, which then produce cytokines such as TNFα as shown by Northern blot and immunostaining. The subsequent granuloma formation could be due to the infiltrated leukocytes (mainly monocytic cells) because the TNFα production in KC is transient, and in turn, that in infiltrated monocytic cells become evident. TNFα produced by monocytic cells must induce other chemokines and cell adhesion molecules to mount further inflammatory leukocytes. It is of note that TNFα is found in KC and the infiltrated monocytes. P. acnes, therefore, may serve as a prolonged CD14 stimulator.
Although CD14 was expressed in hepatocytes in the P. acnes-primed M14M mice, TNFα expression in the KC of these mice in the early period was comparable with that in P. acnes-primed B6 mice. This indicates that P. acnes acts almost equally on KC and extrahepatic monocytic cells, because a large amount of P. acnes (10 µg) may not be eliminated and may thus stimulate not only CD14 but receptors other than CD14, resulting in KC activation. Hence, a comparable degree of leukocyte accumulation will take place in the liver in B6 and M14M mice. Subsequently, newly arrived monocytic cells meet with a small amount of P. acnes, which must be eliminated by the time when they arrive at the liver but be capable of stimulating CD14 in monocytic cells to secrete inflammatory mediators including TNFα. However, hepatocytes especially expressing the membrane CD14 and sCD14 in M14M mice at that time should be expected to effectively eliminate the small amount of P. acnes, reducing the TNFα production, resulting in less marked leukocyte accumulation and granuloma formation.
The levels of upregulation of cytokine and iNOS mRNA in the liver in the P. acnes-primed M14M mice after LPS challenge were less marked compared with those in the P. acnes-primed B6 mice. The low levels of these mRNAs could also be attributed to the elimination of LPS by CD14 which was strongly expressed in the hepatocyte membrane and sCD14. Quantitative and qualitative differences in monocytic cells 7 days after P. acnes-priming could result in differences in hepatocyte damage, since the granuloma formation and TNFα production were less marked in M14M mice 7 days after priming with P. acnes.
An increase in the challenge dose of LPS (2 µg) caused 100% lethality in P. acnes-primed M14M mice without hepatocyte damage, indicating that lethality was not equivalent to hepatocyte damage. The high levels of sCD14 in the sera of the M14M mice prompted us to investigate endothelial activation, because sCD14 when complexed with LPS is capable of binding to endothelial cells and may lead to circulatory disturbances such as increased vascular permeability. We examined ELAM-1 mRNA expression as an indicator for the endothelial cell activation in several organs of M14M mice and found that it was 39.3-58.0% of that in the B6 mice. Therefore, other unknown mechanisms may be involved in lethality of M14M mice.
